Myonexus Therapeutics
Latest round
- Seed
Last raised
- Dec 2017
Total raised
- $4M
Investors
- 4
About Myonexus Therapeutics
Myonexus Therapeutics, Inc.Founded in 2017 and headquartered in New Albany, US, Myonexus Therapeutics, Inc. focuses on gene therapies designed to treat rare muscular dystrophies. In February 2019, the company was acquired by Sarepta Therapeutics, Inc. for USD 165 mn, marking a significant shift in its operational strategy. The acquisition was part of Sarepta's initiative to enhance its capabilities in gene therapy for rare diseases.Myonexus Therapeutics specializes in the development of gene therapies targeting rare muscular dystrophies. The company's product offerings are centered around addressing genetic defects causing these disorders, leveraging advanced gene editing technologies to deliver therapeutic benefits.Myonexus generates revenue through the commercialization of its gene therapies, primarily focusing on hospitals and healthcare providers involved in the treatment of rare muscular dystrophies. The revenue model is based on direct sales agreements, ensuring that affected patients have access to essential therapies that address their specific conditions.Myonexus Therapeutics plans to expand its product line with new gene therapies aimed at various muscular dystrophies, leveraging the resources and infrastructure of Sarepta Therapeutics to accelerate development timelines. Additionally, the company is set to explore new markets, particularly in Europe and Asia, by the end of 2024, responding to the growing need for treatment solutions in these regions.
Who invested in Myonexus Therapeutics
4 investors across 3 rounds
See all investors in Myonexus Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Myonexus Therapeutics
Who invested in Myonexus Therapeutics?
Myonexus Therapeutics has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Myonexus Therapeutics raised?
Myonexus Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Myonexus Therapeutics last raise money?
Myonexus Therapeutics's most recent round on record is a Seed, in Dec 2017.
What does Myonexus Therapeutics do?
Myonexus Therapeutics is a biotechnology company.
Where is Myonexus Therapeutics headquartered?
Myonexus Therapeutics is headquartered in New Albany, US.
Which VCs invest in companies like Myonexus Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Myonexus Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Myonexus Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.